Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-19T06:41:53.658Z Has data issue: false hasContentIssue false

Canadian Association of Neuropathologists Workforce Survey, 2019

Published online by Cambridge University Press:  31 May 2021

P Shannon*
Affiliation:
Mount Sinai Hospital, Toronto
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

To characterize the professional occupation of Canadian neuropathologists and estimate the future employment demands in neuropathologists, all the active members of the Canadian Association of Neuropathologists in Canada (n=53) were surveyed by E-mail, inquiring as to their estimated date of retirement, their current employment and practice profile, and as to any practice trends they had noticed. 49 members replied: all but one practice at medical school centers. 38 practice exclusively in neuropathology and three of these are employed at less than 75% of a full time equivalent. The remaining practices are mixed neuropathology and anatomical pathology, and one practices exclusively ophthalmic pathology. 35% reported significant neuropathology sub specialization (e.g. forensic, pediatric, neuromuscular). 42% reported greater than 10% of time dedicated to research (of these, median 30%) and 35% greater than 10% time spent in teaching, and 9% greater than 10% time in administration. Of the 49 surveyed, as of the spring of 2019, 14%(seven) of the full time neuropathologists can be expected to retire in the next 10 years, and 6% (three) with mixed AP/NP practices.

LEARNING OBJECTIVES

This presentation will enable the learner to:

  1. 1. Understand the current spectrum of practice of Neuropathologists across Canada

  2. 2. Describe the patterns of employment and anticipated retirements of Canadian Neuropathologists

Type
Abstracts
Copyright
© The Canadian Journal of Neurological Sciences Inc. 2021